Neil Vasdev
Neil Vasdev is a Canadian and American radiochemist and expert in nuclear medicine and molecular imaging, particularly in the application of PET.
≈ 9 min read
Neil Vasdev. encyclopegia.org, snapshot enwiki-001378903924. /a/neil-vasdev
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Neil Vasdev is a Canadian and American radiochemist and expert in nuclear medicine and molecular imaging, particularly in the application of PET. Radiotracers developed by the Vasdev Lab are in preclinical use worldwide, and many have been translated for first-in-human neuroimaging studies.[1] Vasdev is the Director of the CAMH Neuroscience Institute, the Chief Radiochemist and Director of the Azrieli Centre for Neuro-Radiochemistry at the Centre for Addiction and Mental Health (CAMH)[2]. He is the Tier 1 Canada Research Chair in Radiochemistry and Medical Imaging, the endowed Azrieli Chair in Brain and Behaviour and Professor of psychiatry at the University of Toronto.[3]
Vasdev has been featured on Global News,[4] CTV,[5] CNN,[6] New York Times,[7][8] Toronto Star[9], New York Post[10], National Geographic[11], CBC News[12], and the Globe and Mail[13] for his innovative research program.
Life and education
edit edit sourceVasdev grew up in Oakville, Ontario, Canada. He attended Oakville Trafalgar High School[14] and graduated from McMaster University in 1998 with double bachelor degrees, summa cum laude, Hon. BSc in chemistry and B.A. in psychology. He concurrently worked as chemist at Astra Pharma and Glaxo-Wellcome. He then earned his Doctorate of Chemistry, supported by NSERC, at McMaster University in 2003, under the supervision of Professors Raman Chirakal and Gary J. Schrobilgen. He continued training with a NSERC postdoctoral fellowship in the Department of Nuclear Medicine and Functional Imaging at the Lawrence Berkeley National Laboratory, mentored by Henry F. VanBrocklin.[15]
Career
edit edit sourceVasdev began his independent faculty career at CAMH/University of Toronto in 2004. From 2011–2017 he served as the Director of Radiochemistry and an Associate Centre Director at the Massachusetts General Hospital and served as an Associate Professor in the Department of Radiology at Harvard Medical School from 2012–2022. He was recruited back to CAMH and the University of Toronto in November 2017.[2]
Research highlights
edit edit sourceIodonium ylide precursors for 18F-labeling
Current methods to radiofluorinate non-activated aromatic rings are generally limited to esoteric electrophilic [18F]F2 reactions, transition-metal mediated, or iodonium salt based methods. The Vasdev Lab has a long-established history of labeling non-activated aromatics and recently discovered a simple synthetic strategy for incorporating [18F]fluoride into non-activated aromatic molecules using spirocyclic iodoium ylide based precursors. Based on their paper in Nature Communications, a patent has been licensed by the pharmaceutical industry to employ this method for the synthesis of radiopharmaceuticals in humans. Hence, the iodonium ylide technology for fluorination represents a major advance for PET imaging.[16]
11C-fixation strategies
edit edit sourceThere is a need for new methods of 11C radiosynthesis because current methods are largely limited to methylation. The Vasdev lab has co-developed new techniques of 11CO2 fixation that are suitable for human use with diverse precursors synthesized by labeling at the carbonyl group (rather than the common methyl group). This methodology can label 11C-carbamates for imaging the enzyme FAAH ([11C]CURB) or 11C-oxazolidinones for imaging MAO-B (11C-SL25.1188), both of which they have translated for human use. They have also synthesized 11C-ureas and a 11C-carboxylic acid (11C-Bexarotene).[17]
New PET radiopharmaceuticals for Alzheimer's disease and brain injuries
edit edit sourceVasdev has introduced new radiochemical methods and radiopharmaceuticals for imaging the living human brain.[18] The Vasdev Lab is exploring new ways to image neuroinflammation and tau protein.[19] He is the co-inventor of the method patent for the first FDA-approved tau-PET radiopharmaceutical Tauvid that has been employed worldwide to image patients with Alzheimer's disease (AD) and related dementias, as well as patients with symptomatic traumatic brain injuries, including professional athletes and military veterans. He also led a collaboration with Merck for the first cGMP production of Tauklarify™[20], and was the first investigator funded by the ADDF and NIH to translate this tau-PET radiopharmaceutical for human use. The Vasdev Lab is partnering with Concussion Legacy Foundation Canada and the Canadian Military to work on the Project Enlist to study whether some military training exercises could be negatively impacting long-term brain health.[4][21][5] "We are getting very close to advancing new radio tracers in humans to image the tau that is more prevalent in C.T.E.".[7]
References
edit edit source- ^ "Neil Vasdev". Canada Research Chairs. Government of Canada. 29 November 2012. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ a b "Dr. Neil Vasdev". CAMH. Retrieved 2026-10-05. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Dr. Neil Vasdev". CAMH. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ a b "Veterans and mental illness — How Canadian research could unlock the mysteries of the brain - National | Globalnews.ca". Global News. Retrieved 2022-11-14. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ a b Petracek, Heidi (Jan 13, 2023). "Researchers investigating head trauma in the Canadian military want veterans to 'pledge their brain'". CTV News. Retrieved Jan 16, 2023. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Kounang, Nadia (2019-04-10). "A study of NFL players' brains might help diagnose CTE in the living". CNN. Retrieved 2023-02-24. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ a b Belson, Ken (November 17, 2022). "A Test for C.T.E. in the Living May Be Closer Than Ever". The New York Times. Retrieved November 17, 2022. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Jacobs, Andrew (2026-09-22). "C.T.E. Can't Be Detected in the Living. New Brain Research Offers Hope". The New York Times. ISSN 0362-4331. Retrieved 2026-10-05. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "'The human brain is the final frontier.' $15M gift from Garron family a boost for CAMH's brain imaging centre". thestar.com. 2020-11-03. Retrieved 2023-02-24. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Behind the race to detect — and treat — brain disease CTE before it kills". 2025-10-14. Retrieved 2026-10-05. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "The Race to Develop a CTE Test for Football Players—While They Are Still Alive". Health. 2026-09-02. Retrieved 2026-10-05. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "CTE ruins lives but can't be confirmed until you're dead. Canadian scientists are trying to change that". June 10, 2026. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Veterans and mental illness — How Canadian research could unlock the mysteries of the brain - National | Globalnews.ca". Global News. Retrieved 2026-10-05. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Oakville native recruited to head new mental health research centre". InsideHalton.com. November 2017. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Neil Vasdev". psychiatry.utoronto.ca. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Stephenson, Nickeisha A.; Holland, Jason P.; Kassenbrock, Alina; Yokell, Daniel L.; Livni, Eli; Liang, Steven H.; Vasdev, Neil (1 March 2015). "Iodonium Ylide–Mediated Radiofluorination of 18F-FPEB and Validation for Human Use". Journal of Nuclear Medicine. 56 (3): 489–492. doi:10.2967/jnumed.114.151332. PMC 4878451. PMID 25655630 – via jnm.snmjournals.org. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Rotstein, Benjamin H.; Liang, Steven H.; Holland, Jason P.; Collier, Thomas Lee; Hooker, Jacob M.; Wilson, Alan A.; Vasdev, Neil (28 May 2013). "11CO2 fixation: a renaissance in PET radiochemistry". Chemical Communications. 49 (50): 5621–5629. doi:10.1039/C3CC42236D. PMC 5604310. PMID 23673726. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Varlow, Cassis; Vasdev, Neil (2022-09-01). "Evaluation of Tau Radiotracers in Chronic Traumatic Encephalopathy". Journal of Nuclear Medicine. 64 (3): 460–465. doi:10.2967/jnumed.122.264404. ISSN 0161-5505. PMC 10071800. PMID 36109185. S2CID 252309243. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Narayanaswami, Vidya; Dahl, Kenneth; Bernard-Gauthier, Vadim; Josephson, Lee; Cumming, Paul; Vasdev, Neil (1 January 2018). "Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO". Molecular Imaging. 17: 153601211879231. doi:10.1177/1536012118792317. PMC 6134492. PMID 30203712. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ Collier, Thomas Lee; Yokell, Daniel L.; Livni, Eli; Rice, Peter A.; Celen, Sofie; Serdons, Kim; Neelamegam, Ramesh; Bormans, Guy; Harris, Dawn; Walji, Abbas; Hostetler, Eric D.; Bennacef, Idriss; Vasdev, Neil (2017-05-15). "cGMP production of the radiopharmaceutical [18 F]MK-6240 for PET imaging of human neurofibrillary tangles". Journal of Labelled Compounds & Radiopharmaceuticals. 60 (5): 263–269. doi:10.1002/jlcr.3496. ISSN 1099-1344. PMID 28185305. Wikipedia revision 1378903924, retrieved 2026-11-18
- ^ "Project Enlist researching military veterans' brains to study CTE | Watch News Videos Online". Global News. Retrieved 2022-11-11. Wikipedia revision 1378903924, retrieved 2026-11-18
External links
edit edit sourceText derived from https://en.wikipedia.org/w/index.php?oldid=1378903924 under CC BY-SA 4.0; modifications have been made.